1.38
-0.01(-0.72%)
Currency In USD
| Previous Close | 1.39 |
| Open | 1.4 |
| Day High | 1.42 |
| Day Low | 1.35 |
| 52-Week High | 2.32 |
| 52-Week Low | 0.92 |
| Volume | 1.31M |
| Average Volume | 1.9M |
| Market Cap | 524.15M |
| PE | -4.31 |
| EPS | -0.32 |
| Moving Average 50 Days | 1.19 |
| Moving Average 200 Days | 1.44 |
| Change | -0.01 |
If you invested $1000 in Standard BioTools Inc. (LAB) 10 years ago, it would be worth $68.9 as of July 31, 2025 at a share price of $1.38. Whereas If you bought $1000 worth of Standard BioTools Inc. (LAB) shares 5 years ago, it would be worth $196.02 as of July 31, 2025 at a share price of $1.38.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Standard BioTools Schedules Second Quarter Earnings Conference Call on August 11, 2025
GlobeNewswire Inc.
Jul 21, 2025 11:00 AM GMT
SOUTH SAN FRANCISCO, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that it will report second quarter 2025 financial results on Monday, August 11, 2025, after market close. The company will host a co
Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina
GlobeNewswire Inc.
Jun 23, 2025 11:05 AM GMT
Up To $425 Million In Total Proceeds Inclusive of Near-term Milestone Payments; $350 Million In Upfront Cash Retains Strategic Upside with Illumina Protein Prep Royalty Stream and Rights to Single SOMAmer Reagent Business Simplifies Operating Str
Standard BioTools to Host Inaugural “Proteomics Roundtable” Webcast Series
GlobeNewswire Inc.
May 30, 2025 11:00 AM GMT
Featuring top researchers and industry experts using high-throughput proteomics to drive breakthroughs in population health, translational research and clinical developmentSOUTH SAN FRANCISCO, Calif., May 30, 2025 (GLOBE NEWSWIRE) -- Standard BioTo